An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Top results in this bookTable of Contents
Guideline: Fortification of Food-Grade Salt with Iodine for the Prevention and Control of Iodine Deficiency Disorders.
Geneva: World Health Organization; 2014.
Practical Approaches to Managing Advanced Kidney Cancer: Version 2020 [Internet].
Rendon R, Kapoor A, authors; Heng DYC, Kollmannsberger C, editors.
Dorval (QC): Canadian Urological Association; 2020.
Pembrolizumab (Keytruda): CADTH Reimbursement Review: Therapeutic area: Triple-negative breast cancer [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Mar.
Inpatient Management of Acute Atrial Fibrillation and Atrial Flutter in Non-Pregnant Hospitalized Adults [Internet].
Rohde JM, Saeed M, Barnes GD, et al.
Ann Arbor (MI): Michigan Medicine University of Michigan; 2021 Nov.
Thyroid disease: assessment and management.
London: National Institute for Health and Care Excellence (NICE); 2019 Nov 20. (NICE Guideline, No. 145.)
Suspected neurological conditions: recognition and referral.
National Guideline Centre (UK).
London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 127.)
Intrapartum care.
London: National Institute for Health and Care Excellence (NICE); 2023 Sep 29. (NICE Clinical Guidelines, No. 235.)
Sedation in Children and Young People: Sedation for Diagnostic and Therapeutic Procedures in Children and Young People [Internet].
National Clinical Guideline Centre (UK).
London: Royal College of Physicians (UK); 2010 Dec. (NICE Clinical Guidelines, No. 112.)
Management of Type 2 Diabetes Mellitus [Internet].
Richardson CR, Borgeson JR, Van Harrison R, et al.
Ann Arbor (MI): Michigan Medicine University of Michigan; 2021 Oct.
Substance Use Disorder Treatment for People With Co-Occurring Disorders: Updated 2020 [Internet].
Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2020. (Treatment Improvement Protocol (TIP) Series, No. 42.)
Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with high-risk early-stage triple-negative breast cancer in combination with chemotherapy as neoadjuvant treatment, and then continued as monotherapy as adjuvant treatment after surgery [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Sep.
Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Indication: In combination with chemotherapy, for the treatment of adult patients with locally recurrent unresectable or metastatic triple-negative breast cancer who have not received prior chemotherapy for metastatic disease and whose tumours express programmed cell death-ligand 1 (combined positive score ≥ 10) as determined by a validated test [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Jan.
Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with unresectable or metastatic microsatellite instability-high or mismatch repair deficient endometrial cancer whose tumours have progressed following prior therapy and who have no satisfactory alternative treatment options, as monotherapy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Feb.
Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Indication: Adjuvant treatment of adult patients with RCC at intermediate-high or high risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Oct.
Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Indication: Adjuvant treatment of adult and pediatric (12 years and older) patients with stage IIB or IIC melanoma following complete resection [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Nov.
Atezolizumab (Tecentriq): CADTH Reimbursement Recommendation: Indication: As monotherapy for adjuvant treatment following resection and platinum-based chemotherapy for patients with non–small cell lung cancer whose tumours have programmed death-ligand 1 expression on 50% or more of tumour cells [Internet].
Pembrolizumab (Keytruda) in Combination With Lenvatinib (Lenvima): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with advanced endometrial carcinoma that is not microsatellite instability high or mismatch repair deficient, who have disease progression following prior platinum-based systemic therapy, and are not candidates for curative surgery or radiation [Internet].
The Guide to Clinical Preventive Services 2012: Recommendations of the U.S. Preventive Services Task Force.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Oct.
Osteoporosis: assessing the risk of fragility fracture.
London: National Institute for Health and Care Excellence (NICE); 2017 Feb. (NICE Clinical Guidelines, No. 146.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on